To benefit global communities through delivery of innovative solutions for the early diagnosis and better management of cancer
Delivering on this vision and mission, Pacific Edge is enabled by its people, their skills, their enthusiasm and their ability to deliver. Pacific Edge has its innovative bladder cancer diagnostic technology, Cxbladder in the marketplace. Pacific Edge’s products are based on proprietary genetic databases used to identify diagnostic biomarkers for cancers. The company specialises in building commercial cancer tests from these proprietary biomarkers.
Pacific Edge’s mission is to improve patient outcomes, provide superior returns to our shareholders and benefits to other stakeholders by developing and commercialising innovative solutions for the early detection and management of cancer. Pacific Edge encompasses a diverse range of expertise covering all stages in the product life cycle from discovery to market. Our capabilities include cancer genetics, molecular oncology, bioinformatics, clinical research, technology commercialisation, marketing and sales.